tradingkey.logo
tradingkey.logo
Search

Rigel Pharmaceuticals Inc

RIGL
Add to Watchlist
36.815USD
-1.245-3.27%
Close 07-31 16:00ETQuotes delayed by 15 min
667.97MMarket Cap
1.82P/E TTM

RIGL Financials

See Rigel Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Rigel Pharmaceuticals Inc Earnings Date

Latest Release
Aug 4, 2026
EPS / Forecast
--/0.81
Revenue / Forecast
--/69.08M
Period
FY2025 Earnings
Revenue(YoY)
294.28M
64.15%
EPS(YoY)
20.40
1951.47%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-26.87%0.47
1711.34%14.72
119.16%1.55
5779.21%3.33
236.55%0.64
1821.06%0.81
316.22%0.71
84.55%-0.06
39.65%-0.47
-57.70%0.04
---0.33
---0.38
---0.78
--0.10
---3.48
----
----
----
----
----
Revenue
10.28%58.82M
21.19%69.80M
25.59%69.46M
176.01%101.69M
80.58%53.33M
60.92%57.60M
96.58%55.31M
37.03%36.84M
13.29%29.53M
-30.20%35.79M
25.54%28.13M
-9.84%26.89M
55.78%26.07M
151.25%51.28M
4.02%22.41M
13.53%29.82M
-79.34%16.73M
10.62%20.41M
17.15%21.54M
63.95%26.27M
Net Profit
-24.39%8.65M
1769.22%268.06M
124.62%27.90M
5887.67%59.61M
238.79%11.45M
1845.86%14.34M
318.22%12.42M
84.39%-1.03M
39.07%-8.25M
-47.39%737.00K
70.10%-5.69M
51.08%-6.60M
50.68%-13.54M
106.19%1.40M
9.14%-19.04M
2.38%-13.49M
-169.48%-27.45M
-17.70%-22.64M
-47.82%-20.95M
21.36%-13.82M
Net Margin
-31.44%14.71%
1442.36%384.04%
78.85%40.17%
2196.90%58.63%
176.86%21.46%
1109.22%24.90%
211.01%22.46%
88.61%-2.80%
46.22%-27.92%
-24.63%2.06%
---20.23%
---24.55%
---51.92%
--2.73%
---86.96%
----
----
----
----
----
Gross Margin
0.48%92.17%
1.69%91.47%
8.97%93.16%
3.45%95.57%
-1.51%91.73%
0.60%89.95%
-10.48%85.49%
-3.77%92.38%
-3.23%93.14%
-9.99%89.41%
--95.49%
--96.00%
--96.25%
--99.33%
--97.96%
----
----
----
----
----
Debt to assets ratio
-73.82%8.89%
-72.02%10.18%
-42.55%24.63%
-37.76%28.93%
-28.04%33.95%
-28.42%36.40%
-17.14%42.87%
-8.63%46.49%
-1.96%47.18%
73.07%50.84%
--51.73%
--50.88%
--48.12%
--29.38%
--34.14%
----
----
----
----
----
Revenue
10.28%58.82M
21.19%69.80M
25.59%69.46M
176.01%101.69M
80.58%53.33M
60.92%57.60M
96.58%55.31M
37.03%36.84M
13.29%29.53M
-30.20%35.79M
25.54%28.13M
-9.84%26.89M
55.78%26.07M
151.25%51.28M
4.02%22.41M
13.53%29.82M
-79.34%16.73M
10.62%20.41M
17.15%21.54M
63.95%26.27M
Operating profit
-6.95%11.88M
39.12%23.17M
102.19%28.42M
13569.57%61.10M
283.36%12.77M
747.15%16.66M
414.80%14.06M
108.49%447.00K
45.26%-6.97M
-42.16%1.97M
75.74%-4.46M
59.38%-5.27M
51.54%-12.72M
118.99%3.40M
6.99%-18.40M
0.64%-12.96M
-162.89%-26.26M
4.94%-17.90M
-43.57%-19.79M
24.98%-13.05M
Net Profit
-24.39%8.65M
1769.22%268.06M
124.62%27.90M
5887.67%59.61M
238.79%11.45M
1845.86%14.34M
318.22%12.42M
84.39%-1.03M
39.07%-8.25M
-47.39%737.00K
70.10%-5.69M
51.08%-6.60M
50.68%-13.54M
106.19%1.40M
9.14%-19.04M
2.38%-13.49M
-169.48%-27.45M
-17.70%-22.64M
-47.82%-20.95M
21.36%-13.82M
Current assets
59.68%234.03M
77.77%240.17M
101.87%214.93M
85.16%175.39M
58.47%146.56M
36.10%135.10M
12.04%106.47M
-6.15%94.72M
-13.54%92.49M
-14.35%99.27M
-13.96%95.02M
-16.26%100.92M
-23.01%106.97M
-24.97%115.90M
-35.45%110.44M
-34.57%120.52M
-29.39%138.94M
73.59%154.47M
71.36%171.10M
62.88%184.20M
Total current liabilities
34.31%89.49M
56.77%99.24M
73.81%94.40M
47.72%86.64M
-8.97%66.63M
18.83%63.30M
12.51%54.31M
33.22%58.65M
60.81%73.20M
-18.32%53.27M
2.13%48.27M
-19.89%44.02M
-23.14%45.52M
2.61%65.21M
-20.27%47.27M
-7.71%54.95M
13.85%59.23M
55.61%63.55M
73.38%59.28M
71.30%59.54M
Total assets
186.75%504.61M
213.21%513.59M
73.96%242.53M
61.00%206.74M
39.09%175.97M
39.88%163.98M
20.89%139.42M
9.67%128.41M
2.35%126.52M
-12.70%117.22M
-0.25%115.32M
-8.52%117.09M
-17.08%123.61M
-19.75%134.28M
-38.02%115.61M
-36.51%128.00M
-30.98%149.07M
51.60%167.33M
51.57%186.52M
46.05%201.60M
Total liabilities
-33.48%104.71M
-24.01%122.11M
-18.91%124.92M
-21.17%124.80M
-0.50%157.41M
10.16%160.69M
4.69%154.06M
9.03%158.32M
6.98%158.19M
-1.37%145.87M
8.65%147.16M
10.27%145.21M
3.93%147.87M
7.99%147.90M
-1.03%135.44M
-1.36%131.68M
3.33%142.28M
79.37%136.95M
89.80%136.85M
78.40%133.49M
Total equity
2053.81%399.90M
11806.33%391.48M
903.56%117.61M
373.90%81.93M
158.62%18.57M
111.48%3.29M
54.02%-14.64M
-6.40%-29.91M
-30.56%-31.67M
-110.37%-28.64M
-60.50%-31.83M
-664.62%-28.11M
-456.83%-24.26M
-144.83%-13.62M
-139.93%-19.83M
-105.40%-3.68M
-91.32%6.80M
-10.73%30.37M
-2.52%49.67M
7.75%68.11M
Net operating income
405.15%2.73M
51.55%21.98M
10.85%24.03M
10011.59%30.54M
82.19%-893.00K
332.42%14.50M
1695.22%21.68M
-94.91%302.00K
-23.05%-5.01M
71.52%-6.24M
89.78%-1.36M
145.93%5.93M
84.11%-4.07M
-14.79%-21.91M
-29.17%-13.30M
-123.38%-12.91M
-28.47%-25.64M
-22.57%-19.09M
47.15%-10.30M
493.33%55.22M
Net investment
24.42%-7.97M
-132.38%-25.36M
-972.57%-33.17M
-312.97%-23.28M
-3471.25%-10.55M
-58.77%-10.91M
424.96%3.80M
267.98%10.93M
-59.72%313.00K
-136.96%-6.87M
-111.19%-1.17M
-85.92%2.97M
-96.57%777.00K
186.65%18.60M
123.55%10.46M
142.48%21.09M
200.44%22.63M
-25.52%6.49M
-327.35%-44.40M
-848.78%-49.66M
Net financing
-2355.99%-10.92M
-412.08%-4.57M
143.40%4.27M
155.59%418.00K
119.27%484.00K
201.44%1.47M
-1032.57%-9.84M
-101.61%-752.00K
-113.14%-2.51M
123.19%486.00K
-115.77%-869.00K
93.41%-373.00K
117.38%19.12M
-293.18%-2.10M
1911.31%5.51M
-109.56%-5.66M
319.50%8.80M
62.67%1.08M
426.92%274.00K
463.13%59.22M

FAQs

What is the total revenue of Rigel Pharmaceuticals Inc?

According to Rigel Pharmaceuticals Inc's FY2025 earnings report, its total revenue reached 294.28M, with a year-on-year change of 179.28M.

What are the current assets of Rigel Pharmaceuticals Inc?

According to Rigel Pharmaceuticals Inc's FY2025 earnings report, its current assets were 240.17M, with a year-on-year change of 77.77.

What are the total assets of Rigel Pharmaceuticals Inc?

According to Rigel Pharmaceuticals Inc's FY2025 earnings report, its total assets of Rigel Pharmaceuticals Inc were 513.59M, with a year-on-year change of 213.21.

What are the total liabilities of Rigel Pharmaceuticals Inc?

According to Rigel Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Rigel Pharmaceuticals Inc were 122.11M, with a year-on-year change of -24.01.

What is the total equity of Rigel Pharmaceuticals Inc?

According to Rigel Pharmaceuticals Inc's FY2025 earnings report, its total equity of Rigel Pharmaceuticals Inc was 391.48M, with a year-on-year change of 11806.33.

What is the net operating income of Rigel Pharmaceuticals Inc?

According to Rigel Pharmaceuticals Inc's FY2025 earnings report, its net operating income of Rigel Pharmaceuticals Inc was 125.47M, with a year-on-year change of 418.63.

What is the net investment of Rigel Pharmaceuticals Inc?

According to Rigel Pharmaceuticals Inc's FY2025 earnings report, its net investment of Rigel Pharmaceuticals Inc was -92.36M, with a year-on-year change of -2336.44.

What is the net financing of Rigel Pharmaceuticals Inc?

According to Rigel Pharmaceuticals Inc's FY2025 earnings report, its net financing of Rigel Pharmaceuticals Inc was 601.00K, with a year-on-year change of 105.16.

What is the Earnings Per Share (EPS) of Rigel Pharmaceuticals Inc?

According to Rigel Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was 20.40, with a year-on-year change of 1951.47.

What is the net income of Rigel Pharmaceuticals Inc?

According to Rigel Pharmaceuticals Inc's FY2025 earnings report, its net income was 367.02M, with a year-on-year change of 1999.08.

What is the net margin of Rigel Pharmaceuticals Inc?

According to Rigel Pharmaceuticals Inc's FY2025 earnings report, its net profit margin was 124.72, with a year-on-year change of 1178.77.

What is the gross margin of Rigel Pharmaceuticals Inc?

According to Rigel Pharmaceuticals Inc's FY2025 earnings report, its gross margin was 93.33, with a year-on-year change of 4.17.

What is the debt-to-asset ratio of Rigel Pharmaceuticals Inc?

According to Rigel Pharmaceuticals Inc's FY2025 earnings report, its debt-to-asset ratio was 10.18, with a year-on-year change of -72.02.

What is the Return on Assets (ROA) of Rigel Pharmaceuticals Inc?

According to Rigel Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was 108.34, with a year-on-year change of 771.15.

What is the operating profit of Rigel Pharmaceuticals Inc?

According to Rigel Pharmaceuticals Inc's FY2025 earnings report, its operating profit was 125.47M, with a year-on-year change of 418.63.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.